{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:50:20Z","timestamp":1782276620394,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2024 \u2013 ID. 30316"],"award-info":[{"award-number":["IG 2024 \u2013 ID. 30316"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PC) progression and mortality are largely driven by therapeutic resistance, increasingly linked to dynamic tumor\u2013stroma interactions. However, the molecular basis of cancer\u2013fibroblast crosstalk remains incompletely understood, particularly the contribution of Interleukin (IL)-30, an emerging regulator of PC aggressiveness. Here, we demonstrate that IL30 produced by PC cells reprograms stromal fibroblasts via IL6R\u03b1\/gp130 signaling, activating AKT and TGF-\u03b2\/BMP pathways to drive their proliferation and differentiation into pro-angiogenic cancer-associated fibroblasts (CAFs). Reciprocally, these fibroblasts amplify IL30-mediated tumor aggressiveness by enhancing oncogenic transcriptional programs and by\u00a0promoting cancer cell migration. Notably, while fibroblast co-culture suppresses epithelial-mesenchymal transition (EMT)-associated genes in PC cells, including NOTCH1, SNAI1\/2 and\u00a0ZEB1, IL30 overexpression overrides this effect, inducing EMT regulators alongside key PC-associated genes, such as IL6, LGALS4, HAL, and SHBG, whose expression correlates with IL30 levels in clinical bone metastasis datasets. Using a two-organ-on-chip platform linking PC\u2013fibroblast spheroids to a bone marrow\u2013like niche, we show that fibroblasts enhance PC cell migration and colonization of the bone marrow microenvironment, effects potentiated by IL30 overexpression and largely abrogated by its genetic depletion. Collectively, these findings identify an IL30\u2013driven tumor\u2013stroma signaling axis that promotes microenvironmental remodeling and metastatic progression, highlighting a potential therapeutic target to counteract PC progression and treatment resistance.<\/jats:p>","DOI":"10.1186\/s43556-026-00482-9","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:43:37Z","timestamp":1782276217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs"],"prefix":"10.1186","volume":"7","author":[{"given":"Stefania Livia","family":"Ciummo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Fieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lanuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-1042","authenticated-orcid":false,"given":"Emma","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"3","key":"482_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"482_CR2","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers13061400","volume":"13","author":"L Berben","year":"2021","unstructured":"Berben L, Floris G, Wildiers H, Hatse S. Cancer and aging: two tightly interconnected biological processes. Cancers (Basel). 2021;13(6):1400. https:\/\/doi.org\/10.3390\/cancers13061400.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"482_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","volume":"22","author":"E Di Carlo","year":"2024","unstructured":"Di Carlo E, Sorrentino C. The multifaceted role of the stroma in the healthy prostate and prostate cancer. J Transl Med. 2024;22(1):825. https:\/\/doi.org\/10.1186\/s12967-024-05564-2.","journal-title":"J Transl Med"},{"issue":"3","key":"482_CR4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/cancers6031298","volume":"6","author":"Y Gong","year":"2014","unstructured":"Gong Y, Chippada-Venkata UD, Oh WK. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel). 2014;6(3):1298\u2013327.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"482_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"issue":"7","key":"482_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell. 2023;41(7):1345-1362.e9. https:\/\/doi.org\/10.1016\/j.ccell.2023.05.016.","journal-title":"Cancer Cell"},{"issue":"1","key":"482_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13148-020-00836-2","volume":"12","author":"MG Lawrence","year":"2020","unstructured":"Lawrence MG, Pidsley R, Niranjan B, Papargiris M, Pereira BA, Richards M, et al. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer. Clin Epigenetics. 2020;12(1):48. https:\/\/doi.org\/10.1186\/s13148-020-00836-2.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"482_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cjp2.205","volume":"7","author":"AB Hesterberg","year":"2021","unstructured":"Hesterberg AB, Rios BL, Wolf EM, Tubbs C, Wong HY, Schaffer KR, et al. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer. J Pathol Clin Res. 2021;7(3):271\u201386. https:\/\/doi.org\/10.1002\/cjp2.205.","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"482_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-01099-2","volume":"32","author":"Z Cao","year":"2025","unstructured":"Cao Z, Quazi S, Arora S, Osellame LD, Burvenich IJ, Janes PW, et al. Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. J Biomed Sci. 2025;32(1):7. https:\/\/doi.org\/10.1186\/s12929-024-01099-2.","journal-title":"J Biomed Sci"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41420-020-0272-5","volume":"6","author":"EH Cheteh","year":"2020","unstructured":"Cheteh EH, Sarne V, Ceder S, Bianchi J, Augsten M, Rundqvist H, et al. Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells. Cell Death Discov. 2020;6:42. https:\/\/doi.org\/10.1038\/s41420-020-0272-5.","journal-title":"Cell Death Discov"},{"issue":"1","key":"482_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41698-021-00160-9","volume":"5","author":"F Su","year":"2021","unstructured":"Su F, Daquinag AC, Ahn S, Saha A, Dai Y, Zhao Z, et al. Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium. npj Precis Oncol. 2021;5(1):26. https:\/\/doi.org\/10.1038\/s41698-021-00160-9.","journal-title":"npj Precis Oncol"},{"issue":"6","key":"482_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/s1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16(6):779\u201390. https:\/\/doi.org\/10.1016\/s1074-7613(02)00324-2.","journal-title":"Immunity"},{"issue":"3","key":"482_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1078-0432.CCR-13-2240","volume":"20","author":"S Di Meo","year":"2014","unstructured":"Di Meo S, Airoldi I, Sorrentino C, Zorzoli A, Esposito S, Di Carlo E. Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage. Clin Cancer Res. 2014;20(3):585\u201394. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-2240.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"482_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s40425-019-0668-z","volume":"7","author":"C Sorrentino","year":"2019","unstructured":"Sorrentino C, Yin Z, Ciummo S, Lanuti P, Lu LF, Marchisio M, et al. Targeting Interleukin(IL)-30\/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival. J Immunother Cancer. 2019;7(1):201. https:\/\/doi.org\/10.1186\/s40425-019-0668-z.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"482_CR15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.24814","volume":"55","author":"D Dibra","year":"2012","unstructured":"Dibra D, Cutrera J, Xia X, Kallakury B, Mishra L, Li S. Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology. 2012;55(4):1204\u201314. https:\/\/doi.org\/10.1002\/hep.24814.","journal-title":"Hepatology"},{"issue":"3","key":"482_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/cells9030615","volume":"9","author":"E Di Carlo","year":"2020","unstructured":"Di Carlo E. Decoding the role of Interleukin-30 in the crosstalk between cancer and myeloid cells. Cells. 2020;9(3):615. https:\/\/doi.org\/10.3390\/cells9030615.","journal-title":"Cells"},{"issue":"6","key":"482_CR17","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1074\/jbc.M112.432955","volume":"288","author":"C Garbers","year":"2013","unstructured":"Garbers C, Spudy B, Aparicio-Siegmund S, Waetzig GH, Sommer J, H\u00f6lscher C, et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL30) via a gp130 protein receptor homodimer. J Biol Chem. 2013;288(6):4346\u201354. https:\/\/doi.org\/10.1074\/jbc.M112.432955.","journal-title":"J Biol Chem"},{"issue":"1","key":"482_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-022-01357-6","volume":"15","author":"C Sorrentino","year":"2022","unstructured":"Sorrentino C, D\u2019Antonio L, Ciummo SL, Fieni C, Landuzzi L, Ruzzi F, et al. CRISPR\/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality. J Hematol Oncol. 2022;15(1):145. https:\/\/doi.org\/10.1186\/s13045-022-01357-6.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"482_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13046-023-02902-y","volume":"42","author":"SL Ciummo","year":"2023","unstructured":"Ciummo SL, Sorrentino C, Fieni C, Di Carlo E. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. J Exp Clin Cancer Res. 2023;42(1):336. https:\/\/doi.org\/10.1186\/s13046-023-02902-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"482_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","volume":"21","author":"G Epstein Shochet","year":"2020","unstructured":"Epstein Shochet G, Brook E, Bardenstein-Wald B, Shitrit D. TGF-\u03b2 pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling. Respir Res. 2020;21(1):56. https:\/\/doi.org\/10.1186\/s12931-020-1319-0.","journal-title":"Respir Res"},{"issue":"7","key":"482_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/15384047.2019.1591122","volume":"20","author":"HF Zhu","year":"2019","unstructured":"Zhu HF, Zhang XH, Gu CS, Zhong Y, Long T, Ma YD, et al. Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B. Cancer Biol Ther. 2019;20(7):967\u201378. https:\/\/doi.org\/10.1080\/15384047.2019.1591122.","journal-title":"Cancer Biol Ther"},{"key":"482_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.matbio.2015.01.013","volume":"44-46","author":"S Cal","year":"2015","unstructured":"Cal S, L\u00f3pez-Ot\u00edn C. ADAMTS proteases and cancer. Matrix Biol. 2015;44\u201346:77\u201385. https:\/\/doi.org\/10.1016\/j.matbio.2015.01.013.","journal-title":"Matrix Biol"},{"issue":"Pt B","key":"482_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2023.05.010","volume":"155","author":"J Petrik","year":"2024","unstructured":"Petrik J, Lauks S, Garlisi B, Lawler J. Thrombospondins in the tumor microenvironment. Semin Cell Dev Biol. 2024;155(Pt B):3\u201311. https:\/\/doi.org\/10.1016\/j.semcdb.2023.05.010.","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"482_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/cancers13050935","volume":"13","author":"S Nallanthighal","year":"2021","unstructured":"Nallanthighal S, Heiserman JP, Cheon DJ. Collagen Type XI Alpha 1 (COL11A1): a novel biomarker and a key player in cancer. Cancers (Basel). 2021;13(5):935. https:\/\/doi.org\/10.3390\/cancers13050935.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"482_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ccr.2011.02.007","volume":"19","author":"DB Stairs","year":"2011","unstructured":"Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, Kalabis J, et al. Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell. 2011;19(4):470\u201383. https:\/\/doi.org\/10.1016\/j.ccr.2011.02.007.","journal-title":"Cancer Cell"},{"issue":"6","key":"482_CR26","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/ijms25063191","volume":"25","author":"WT Lee","year":"2024","unstructured":"Lee WT, Wu PY, Cheng YM, Huang YF. Tissue Inhibitor of Metalloproteinase 3: unravelling its biological function and significance in oncology. Int J Mol Sci. 2024;25(6):3191. https:\/\/doi.org\/10.3390\/ijms25063191.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"482_CR27","doi-asserted-by":"publisher","first-page":"e2024258118","DOI":"10.1073\/pnas.2024258118","volume":"118","author":"NK Jegadesan","year":"2021","unstructured":"Jegadesan NK, Branzei D. DDX11 loss causes replication stress and pharmacologically exploitable DNA repair defects. Proc Natl Acad Sci U S A. 2021;118(17):e2024258118. https:\/\/doi.org\/10.1073\/pnas.2024258118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"482_CR28","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1038\/s41598-023-35793-2","volume":"13","author":"B Yan","year":"2023","unstructured":"Yan B, Guo J, Deng S, Chen D, Huang M. A pan-cancer analysis of the role of USP5 in human cancers. Sci Rep. 2023;13(1):8972. https:\/\/doi.org\/10.1038\/s41598-023-35793-2.","journal-title":"Sci Rep"},{"issue":"1","key":"482_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/jca.58982","volume":"13","author":"YZ Li","year":"2022","unstructured":"Li YZ, Zhang C, Pei JP, Zhang WC, Zhang CD, Dai DQ. The functional role of Pescadillo ribosomal biogenesis factor 1 in cancer. J Cancer. 2022;13(1):268\u201377. https:\/\/doi.org\/10.7150\/jca.58982.","journal-title":"J Cancer"},{"issue":"19","key":"482_CR30","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1158\/0008-5472.can-16-0641","volume":"76","author":"CH Tsai","year":"2016","unstructured":"Tsai CH, Tzeng SF, Chao TK, Tsai CY, Yang YC, Lee MT, et al. Metastatic progression of prostate cancer is mediated by autonomous binding of galectin-4-O-glycan to cancer cells. Cancer Res. 2016;76(19):5756\u201367. https:\/\/doi.org\/10.1158\/0008-5472.can-16-0641.","journal-title":"Cancer Res"},{"issue":"1","key":"482_CR31","doi-asserted-by":"publisher","first-page":"12327","DOI":"10.1038\/s41598-020-69338-8","volume":"10","author":"L Gheghiani","year":"2020","unstructured":"Gheghiani L, Shang S, Fu Z. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer. Sci Rep. 2020;10(1):12327. https:\/\/doi.org\/10.1038\/s41598-020-69338-8.","journal-title":"Sci Rep"},{"issue":"16","key":"482_CR32","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/pros.23056","volume":"75","author":"HA Adissu","year":"2015","unstructured":"Adissu HA, McKerlie C, Di Grappa M, Waterhouse P, Xu Q, Fang H, et al. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer. Prostate. 2015;75(16):1831\u201343. https:\/\/doi.org\/10.1002\/pros.23056.","journal-title":"Prostate"},{"issue":"44","key":"482_CR33","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1038\/sj.onc.1205814","volume":"21","author":"L Liu","year":"2002","unstructured":"Liu L, Yoon JH, Dammann R, Pfeifer GP. Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene. 2002;21(44):6835\u201340. https:\/\/doi.org\/10.1038\/sj.onc.1205814.","journal-title":"Oncogene"},{"issue":"10","key":"482_CR34","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S1470-2045(07)70280-2","volume":"8","author":"LY Khor","year":"2007","unstructured":"Khor LY, Bae K, Pollack A, Hammond ME, Grignon DJ, Venkatesan VM, et al. COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. Lancet Oncol. 2007;8(10):912\u201320. https:\/\/doi.org\/10.1016\/S1470-2045(07)70280-2.","journal-title":"Lancet Oncol"},{"issue":"9","key":"482_CR35","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1158\/2159-8290.CD-20-1765","volume":"11","author":"A Papachristodoulou","year":"2021","unstructured":"Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk RK, Milner TA, et al. NKX3.1 localization to mitochondria suppresses prostate cancer initiation. Cancer Discov. 2021;11(9):2316\u201333. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1765.","journal-title":"Cancer Discov"},{"issue":"5","key":"482_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Sch\u00f6pfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578\u201383. https:\/\/doi.org\/10.1053\/hp.2000.6698.","journal-title":"Hum Pathol"},{"issue":"11","key":"482_CR37","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1016\/j.ymthe.2024.09.011","volume":"32","author":"C Fieni","year":"2024","unstructured":"Fieni C, Ciummo SL, Sorrentino C, Marchetti S, Vespa S, Lanuti P, et al. Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing. Mol Ther. 2024;32(11):3932\u201354. https:\/\/doi.org\/10.1016\/j.ymthe.2024.09.011.","journal-title":"Mol Ther"},{"issue":"4","key":"482_CR38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841-856.e16. https:\/\/doi.org\/10.1016\/j.cell.2018.01.009.","journal-title":"Cell"},{"issue":"114504","key":"482_CR39","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, et al. Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting. Adv Drug Deliv Rev. 2022;189(114504):114504. https:\/\/doi.org\/10.1016\/j.addr.2022.114504.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"482_CR40","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175. https:\/\/doi.org\/10.1038\/s41467-025-57465-7.","journal-title":"Nat Commun"},{"key":"482_CR41","doi-asserted-by":"publisher","first-page":"1133160","DOI":"10.3389\/fimmu.2023.1133160","volume":"14","author":"J Pan","year":"2023","unstructured":"Pan J, Ma Z, Liu B, Qian H, Shao X, Liu J, et al. Identification of cancer-associated fibroblasts subtypes in prostate cancer. Front Immunol. 2023;14:1133160. https:\/\/doi.org\/10.3389\/fimmu.2023.1133160.","journal-title":"Front Immunol"},{"issue":"1","key":"482_CR42","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1038\/s41467-024-53233-1","volume":"15","author":"K Zhang","year":"2024","unstructured":"Zhang K, Liu K, Hu B, Du G, Chen X, Xiao L, et al. Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. Nat Commun. 2024;15(1):9050. https:\/\/doi.org\/10.1038\/s41467-024-53233-1.","journal-title":"Nat Commun"},{"key":"482_CR43","doi-asserted-by":"publisher","first-page":"613534","DOI":"10.3389\/fcell.2021.613534","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Yang Q, Tan Y, Tang Y, Ye J, Yuan B, et al. Cancer-associated fibroblasts suppress cancer development: the other side of the coin. Front Cell Dev Biol. 2021;9:613534. https:\/\/doi.org\/10.3389\/fcell.2021.613534.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"482_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12929-025-01209-8","volume":"33","author":"E Di Carlo","year":"2026","unstructured":"Di Carlo E. Tumor-on-chip\u2019s alliance with molecular pathology against metastatic disease. J Biomed Sci. 2026;33(1):9. https:\/\/doi.org\/10.1186\/s12929-025-01209-8.","journal-title":"J Biomed Sci"},{"issue":"9","key":"482_CR45","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1038\/s12276-024-01310-2","volume":"56","author":"C Fieni","year":"2024","unstructured":"Fieni C, Sorrentino C, Ciummo SL, Fontana A, Lotti LV, Scialis S, et al. Immunoliposome-based targeted delivery of the CRISPR\/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival. Exp Mol Med. 2024;56(9):2033\u201351. https:\/\/doi.org\/10.1038\/s12276-024-01310-2.","journal-title":"Exp Mol Med"},{"issue":"1","key":"482_CR46","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","volume":"22","author":"AO Giarratana","year":"2024","unstructured":"Giarratana AO, Prendergast CM, Salvatore MM, Capaccione KM. TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer. J Transl Med. 2024;22(1):594. https:\/\/doi.org\/10.1186\/s12967-024-05411-4.","journal-title":"J Transl Med"},{"issue":"3","key":"482_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00441-016-2407-9","volume":"365","author":"KP Conroy","year":"2016","unstructured":"Conroy KP, Kitto LJ, Henderson NC. \u0391v integrins: key regulators of tissue fibrosis. Cell Tissue Res. 2016;365(3):511\u20139. https:\/\/doi.org\/10.1007\/s00441-016-2407-9.","journal-title":"Cell Tissue Res"},{"issue":"110416","key":"482_CR48","doi-asserted-by":"publisher","first-page":"110416","DOI":"10.1016\/j.biopha.2020.110416","volume":"129","author":"MX Xiu","year":"2020","unstructured":"Xiu MX, Liu YM, Kuang BH. The oncogenic role of Jagged1\/Notch signaling in cancer. Biomed Pharmacother. 2020;129(110416):110416. https:\/\/doi.org\/10.1016\/j.biopha.2020.110416.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"482_CR49","doi-asserted-by":"publisher","first-page":"e30654","DOI":"10.1016\/j.heliyon.2024.e30654","volume":"10","author":"M Mao","year":"2024","unstructured":"Mao M, Chen W, Ye D. Research progress on the structure, function, and use of angiogenin in malignant tumours. Heliyon. 2024;10(9):e30654. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30654.","journal-title":"Heliyon"},{"issue":"1","key":"482_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ. TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol. 2021;18(1):9\u201334. https:\/\/doi.org\/10.1038\/s41571-020-0403-1.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"482_CR51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin Cancer Res. 2020;26(2):487\u2013504. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1868.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"482_CR52","doi-asserted-by":"publisher","first-page":"e002966","DOI":"10.1136\/jitc-2021-002966","volume":"9","author":"C Sorrentino","year":"2021","unstructured":"Sorrentino C, Ciummo SL, D\u2019Antonio L, Fieni C, Lanuti P, Turdo A, et al. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. J Immunother Cancer. 2021;9(10):e002966. https:\/\/doi.org\/10.1136\/jitc-2021-002966.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"482_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/jca.49560","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang H, Liu S, Cai Z, Dong W, Ye J, Cai Z, et al. Down-regulation of ACACA suppresses the malignant progression of prostate cancer through inhibiting mitochondrial potential. J Cancer. 2021;12(1):232\u201343. https:\/\/doi.org\/10.7150\/jca.49560.","journal-title":"J Cancer"},{"issue":"12","key":"482_CR54","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41416-020-01052-8","volume":"123","author":"P Nasta\u0142y","year":"2020","unstructured":"Nasta\u0142y P, Stoupiec S, Pop\u0119da M, Smentoch J, Schlomm T, Morrissey C, et al. EGFR as a stable marker of prostate cancer dissemination to bones. Br J Cancer. 2020;123(12):1767\u201374. https:\/\/doi.org\/10.1038\/s41416-020-01052-8.","journal-title":"Br J Cancer"},{"issue":"1","key":"482_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1):129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"482_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.onc.1209769","volume":"26","author":"JS Zhang","year":"2007","unstructured":"Zhang JS, Gong A, Young CYF. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer. Oncogene. 2007;26(1):111\u201322. https:\/\/doi.org\/10.1038\/sj.onc.1209769.","journal-title":"Oncogene"},{"issue":"2","key":"482_CR57","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3892\/ol.2018.8960","volume":"16","author":"S Zhang","year":"2018","unstructured":"Zhang S, Li B, Tang W, Ni L, Ma H, Lu M, et al. Effects of connective tissue growth factor on prostate cancer bone metastasis and osteoblast differentiation. Oncol Lett. 2018;16(2):2305\u201311. https:\/\/doi.org\/10.3892\/ol.2018.8960.","journal-title":"Oncol Lett"},{"issue":"7715","key":"482_CR58","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/d41586-018-05573-4","volume":"559","author":"C Frezza","year":"2018","unstructured":"Frezza C. Histidine metabolism boosts cancer therapy. Nature. 2018;559(7715):484\u20135. https:\/\/doi.org\/10.1038\/d41586-018-05573-4.","journal-title":"Nature"},{"issue":"106606","key":"482_CR59","doi-asserted-by":"publisher","first-page":"106606","DOI":"10.1016\/j.jsbmb.2024.106606","volume":"245","author":"AG Mukherjee","year":"2025","unstructured":"Mukherjee AG, G AV. Sex hormone-binding globulin and its critical role in prostate cancer: a comprehensive review. J Steroid Biochem Mol Biol. 2025;245(106606):106606. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106606.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"482_CR60","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2017.02.003","volume":"31","author":"JB Wu","year":"2017","unstructured":"Wu JB, Yin L, Shi C, Li Q, Duan P, Huang JM, et al. MAOA-dependent activation of Shh-IL6-RANKL signaling network promotes prostate cancer metastasis by engaging tumor-stromal cell interactions. Cancer Cell. 2017;31(3):368\u201382. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.003.","journal-title":"Cancer Cell"},{"key":"482_CR61","doi-asserted-by":"publisher","unstructured":"Tzeng SF, Tsai CH, Chao TK, Chou YC, Yang YC, Tsai MH, et al. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer. FASEB J. 2018:fj201800687. https:\/\/doi.org\/10.1096\/fj.201800687.","DOI":"10.1096\/fj.201800687"},{"issue":"2","key":"482_CR62","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms26020776","volume":"26","author":"P Yao","year":"2025","unstructured":"Yao P, Cao S, Zhu Z, Wen Y, Guo Y, Liang W, et al. Cellular signaling of amino acid metabolism in prostate cancer. Int J Mol Sci. 2025;26(2):776. https:\/\/doi.org\/10.3390\/ijms26020776.","journal-title":"Int J Mol Sci"},{"issue":"29","key":"482_CR63","doi-asserted-by":"publisher","first-page":"26618","DOI":"10.1074\/jbc.M202495200","volume":"277","author":"DJ Hryb","year":"2002","unstructured":"Hryb DJ, Nakhla AM, Kahn SM, St George J, Levy NC, Romas NA, et al. Sex hormone-binding globulin in the human prostate is locally synthesized and may act as an autocrine\/paracrine effector. J Biol Chem. 2002;277(29):26618\u201322. https:\/\/doi.org\/10.1074\/jbc.M202495200.","journal-title":"J Biol Chem"},{"issue":"14","key":"482_CR64","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/cancers13143478","volume":"13","author":"OA Bamodu","year":"2021","unstructured":"Bamodu OA, Tzou KY, Lin CD, Hu SW, Wang YH, Wu WL, et al. Differential but concerted expression of HSD17B2, HSD17B3, SHBG and SRD5A1 testosterone tetrad modulate therapy response and susceptibility to disease relapse in patients with prostate cancer. Cancers (Basel). 2021;13(14):3478. https:\/\/doi.org\/10.3390\/cancers13143478.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"482_CR65","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1038\/s41598-020-67289-8","volume":"10","author":"G Carpentier","year":"2020","unstructured":"Carpentier G, Berndt S, Ferratge S, Rasband W, Cuendet M, Uzan G, et al. Angiogenesis analyzer for ImageJ - A comparative morphometric analysis of \u201cendothelial tube formation assay\u201d and \u201cfibrin bead assay.\u201d Sci Rep. 2020;10(1):11568. https:\/\/doi.org\/10.1038\/s41598-020-67289-8.","journal-title":"Sci Rep"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00482-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:43:42Z","timestamp":1782276222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00482-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00482-9","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal procedures were performed in accordance with the European Community and ARRIVE guidelines and were approved by the Institutional Animal Care Committee of \u201cG. d\u2019Annunzio\u201d University and by the Italian Ministry of Health (Authorization n. 409\/2025-PR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}